Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials-Reference-Cited by-同舟云学术

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

Published:2009-03-15 Issue:6 Volume:115 Page:1234-1244
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

du Bois Andreas,Reuss Alexander,Pujade-Lauraine Eric,Harter Philipp,Ray-Coquard Isabelle,Pfisterer Jacobus

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference34 articles.

1. Cancer statistics, 2006;Jemal;CA Cancer J Clin.,2006

2. Estimates of the cancer incidence and mortality in Europe in 2006;Ferlay;Ann Oncol.,2007

3. consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004);du Bois;Ann Oncol.,2004

4. Predictors of comprehensive surgical treatment in patients with ovarian cancer;Goff;Cancer.,2007

5. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients;Earle;J Natl Cancer Inst.,2006

Cited by 1260 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of molecular testing on the surgical management of advanced epithelial ovarian cancer;Critical Reviews in Oncology/Hematology;2024-10

2. British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-09

3. The paradigm shift in advanced ovarian cancer: Outcomes of extensive primary cytoreductive surgery. A single-center retrospective analysis;European Journal of Surgical Oncology;2024-09

4. Anti-cancer effects of benzimidazole derivative BNZ-111 on paclitaxel-resistant ovarian cancer;Gynecologic Oncology;2024-09

5. Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma;O&G Open;2024-09